Cosmos Health (COSM) Net Equity Issued and Repurchased (2010 - 2026)

Cosmos Health (COSM) has 9 years of Net Equity Issued and Repurchased data on file, last reported at $1.8 million in Q1 2026.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.1 million (up 176.2% YoY) and the FY2025 annual result came in at $5.4 million, up 734.68% from the prior year.
• Net Equity Issued and Repurchased eased to $1.8 million in Q1 2026, from $5.3 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $6.0 million in Q4 2022 to a low of -$10.0 million in Q4 2023.
• A 5-year average of $2.0 million and a median of $4.8 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2023 — Net Equity Issued and Repurchased sank 265.83% — and 2024, when it sank 86.34%.
• Tracing COSM's Net Equity Issued and Repurchased over 5 years: stood at $6.0 million in 2022, then slumped by 265.83% to -$10.0 million in 2023, then soared by 106.52% to $649039.0 in 2024, then surged by 709.64% to $5.3 million in 2025, then tumbled by 65.13% to $1.8 million in 2026.
• The last three Net Equity Issued and Repurchased figures came in at $1.8 million (Q1 2026), $5.3 million (Q4 2025), and $649039.0 (Q1 2024), per Business Quant data.